silybin has been researched along with Nasopharyngeal Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Amir-Tidadini, ZC; Bourouba, M; Chettibi, F; Djennaoui, D; Merghoub, T; Ouahioune, W; Sellam, LS; Touil-Boukoffa, C; Yahi-Ait Mesbah, N; Zappasodi, R | 1 |
1 other study(ies) available for silybin and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; B7-H1 Antigen; Biopsy; Cell Line, Tumor; Cell Proliferation; Citric Acid Cycle; Down-Regulation; Drug Discovery; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactate Dehydrogenase 5; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxidative Phosphorylation; Signal Transduction; Silybin | 2020 |